Curr Opin Investig Drugs. 2005 May;6(5):467-72.

The potential use of PPARalpha agonists as immunosuppressive agents.

Source

Research and Medicine Services, Division of Nephrology, San Diego, CA 92161, USA. rcunard@ucsd.edu

Abstract

Fibrates are peroxisome proliferator-activated receptor (PPAR)alpha ligands that have been used to treat hyperlipidemia and atherosclerosis for many years, and research has demonstrated that these agents have immunosuppressive effects. PPARalpha is expressed in multiple inflammatory cell types, and its ligands abrogate expression of inflammatory diseases. This review focuses on the use of fibrates in inflammatory disease models. It also describes proposed mechanisms of action of PPARalpha ligands and discusses the potential use of these medications as immunosuppressive agents.

PMID:: 15912959; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Review Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. [Vascul Pharmacol. 2006]
Review Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM, Schiffrin EL. Vascul Pharmacol. 2006 Jul; 45(1):19-28. Epub 2006 Jun 16.
Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression. [Mol Immunol. 2007]
Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression.
Selim E, Frkanec JT, Cunard R. Mol Immunol. 2007 Feb; 44(6):1218-29. Epub 2006 Sep 1.
Review Factors modulating fibrates response: therapeutic implications and alternative strategies. [Endocr Metab Immune Disord Dru...]
Review Factors modulating fibrates response: therapeutic implications and alternative strategies.
Panadero MI, González MC, Herrera E, Bocos C. Endocr Metab Immune Disord Drug Targets. 2009 Sep; 9(3):219-36. Epub 2009 Sep 1.
Review Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis. [Curr Drug Targets Cardiovasc H...]
Review Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.
Gouni-Berthold I, Krone W. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec; 5(6):513-23.
Review Therapeutical effects of PPAR agonists assessed by biomarker modulation. [Biomarkers. 2005]
Review Therapeutical effects of PPAR agonists assessed by biomarker modulation.
Chinetti-Gbaguidi G, Fruchart JC, Staels B. Biomarkers. 2005 Nov; 10 Suppl 1:S30-6.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Gemfibrozil, stretching arms beyond lipid lowering. [Immunopharmacol Immunotoxicol....]
Review Gemfibrozil, stretching arms beyond lipid lowering.
Roy A, Pahan K. Immunopharmacol Immunotoxicol. 2009; 31(3):339-51.
Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines. [PPAR Res. 2007]
Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines.
Martinasso G, Oraldi M, Trombetta A, Maggiora M, Bertetto O, Canuto RA, Muzio G. PPAR Res. 2007; 2007:93416.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The potential use of PPARalpha agonists as immunosuppressive agents.
The potential use of PPARalpha agonists as immunosuppressive agents.
Curr Opin Investig Drugs. 2005 May ;6(5):467-72.

PubMed
[A new treatment of keratectasia after LASIK by using collagen with riboflavin/U...
[A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking].
Klin Monbl Augenheilkd. 2005 May ;222(5):430-6.

PubMed
Enhanced expression of the mannose receptor by endothelial cells of the liver an...
Enhanced expression of the mannose receptor by endothelial cells of the liver and spleen microvascular beds in the macrophage-deficient PU.1 null mouse.
Histochem Cell Biol. 2005 Jun ;123(4-5):365-76. Epub 2005 May 24 .

PubMed
Investigating gender-related construct-irrelevant components of scores on the wr...
Investigating gender-related construct-irrelevant components of scores on the written assessment exercise of a high-stakes certification assessment.
Adv Health Sci Educ Theory Pract. 2005 ;10(1):53-63.

PubMed
A Randomized Study of Epithelial Ovarian Cancer: Is Chemotherapy Useful after Co...
A Randomized Study of Epithelial Ovarian Cancer: Is Chemotherapy Useful after Complete Remission?
Int J Med Sci. 2004;1(2):116-125. Epub 2004 Jun 1.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: